臨床研究等提出・公開システム

Clinical application of a wearable integrated volitional control electrical stimulation device for patient with motor disability in upper extremity at subacute phase.

Clinical application of a WIVES device for patient with motor disability in upper extremity at subacute phase

Mikami Yasuo

University Hospital, Kyoto Prefectural University of Medicine

465 Kajii-cho, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto, 602-8566, Japan

reha@koto.kpu-m.ac.jp

Ohashi Suzuyo

University Hospital, Kyoto Prefectural University of Medicine

465 Kajii-cho, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto, 602-8566, Japan

+81-75-251-5552

reha@koto.kpu-m.ac.jp

Recruiting

Mar. 17, 2016

Interventional

randomized controlled trial

open(masking not used)

active control

parallel assignment

treatment purpose

Inclusion criteria is as following: 1) the patient with motor disability in upper extremity, 2)Those who passed within 180 days since onset, 3) It is possible to detect the electromyogram of finger extension using the integrated volitional control electrical stimulation device.

Exclusion criteria is as following: 1) severe limited range of motion in wrist (wrist dorsiflexion<0 degree), 2) severe sensory disturbance (loss of superficial or deep sense), 3) severe higher brain dysfunction (Mini-mental state examination 23 points or less), 4) patient who already treated with combination therapy such as transcranial magnetic stimulation, Botulinum toxin therapy, constraint induced movement therapy, or rehabilitation robot, 5) patients with the contraindication of electrical stimulation therapy (Cardiovascular disease, Inserting a metal into the body like a pace maker, Infection, malignant tumor, use of metal implants for upper extremity, Abnormal blood pressure, Parts of abnormal skin, acute disease, Blood flow disturbance, pregnant woman)

Both

Stroke, Traumatic brain injury, spinal cord injury, peripheral nerve injury

The intervention group attaches a wearable integrated volitional control electrical stimulation device for 6 hours a day, 28 days. The target muscle is extensor digitorum muscle. The patient actively uses paralyzed upper extremity in daily life. Therapy are performed physical therapy, occupational therapy and speech-language-hearing therapy, total 180 minutes a day at most. The control group attaches a conventional integrated volitional control electrical stimulation device for 6 hours a day, 28 days. The target muscle is extensor digitorum muscle. The patient actively uses paralyzed upper extremity in daily life. Therapy are performed physical therapy, occupational therapy and speech-language-hearing therapy, total 180 minutes a day at most.

Fugl-Meyer assessment score for upper extremity

1) Motor Activity Log (MAL)
2) Wolf Motor Function Test (WMFT)
3) Active range of motion (active ROM)
4) Action Research Arm Test (ARAT)
5) Modified Ashworth Scale (MAS)
6) Stroke Impairment Assessment Set (SIAS)
7) Brunnstrom stage test (Br.stage)
8) Functional Independence Measure (FIM)
9) Time to mount the devices
10) Feeling of use and fit of the devices

+81-75-251-5337

Feb. 01, 2019

No

None